drugset / Trial / NCT03002025
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants
RandomizedParallel-groupDouble-blindOther
Summary
The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics (PK) following single-dose subcutaneous (SC) injection of JNJ-64304500 in healthy Japanese male participants.
Timeline
- Start
- 2017-01-10
- Primary completion
- 2017-09-09
- Completion
- 2017-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-64304500 | Unknown | 50 mg | Subcutaneous |
| Subject | JNJ-64304500 | Unknown | 150 mg | Subcutaneous |
| Subject | JNJ-64304500 | Unknown | 400 mg | Subcutaneous |
Indications
No indication recorded.